Medicine a
ERR agonists, including SLU-PP-332 and SLU-PP-915, enhance mitochondrial oxidative capacity, promote FAO, reduce fibrosis, and preserve contractile function in preclinical studies, suggesting potential targeted metabolic therapies (Xu et al., 2024a)
If youre not comfortable with traditional needles, its worth knowing about alternatives that can make your treatment easier
o Biocon Limited Advanced Pipeline Companies o Boehringer Ingelheim International GmbH o Amgen Inc
[25] Aller R, Izaola O, Gmez S, et al
Methylation pathways become saturated, and excess methionine is converted to homocysteine, which may contribute to cardiovascular risk if B-vitamin cofactors (B6, B12, folate) aren't adequate